“Medicine heals doubts as well as diseases.” - Karl Marx

Founder & Director Message

It is pleased to inform you that the TPA is available online as well as to receive your support all through the course of its journey. TPA was launched in the month of January 2013 with an objective...

Read more
Total No. of Scholars:- 77

Director World Wide Invitations

Dr. Shelena Ashley

Prof. Satyanand Tyagi is cordially invited by Dr. Shelena Ashley, Program Manager....

Dr. K Petrotos

Prof. Satyanand Tyagi was invited by Dr. K Petrotos, Head of the Conference ....

Mr. Isaac Samuel

Prof. Satyanand Tyagi was invited by Mr. Isaac Samuel, One of the Member of Metab....

Ms. Janice Jiang

Prof. Satyanand Tyagi was invited by Ms. Janice Jiang (From Hui Xian Yuan, Dalian Hi-tech I....

Read more

TPA Latest World Wide Pharma. News
1) FDA Approves Jardiance (Empagliflozin) to Treat Type 2 Diabetes.

The U.S. Food and Drug Administration recently approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Jardiance is a sodium gluc... Read More

2) FDA Approves Plegridy (Peginterferon beta-1a) for the Treatment of Multiple Sclerosis.

Biogen Idec announced that the U.S. Food and Drug Administration (FDA) has approved Plegridy (peginterferon beta-1a), a new treatment for people with relapsing forms of multiple sclerosis (RMS). Plegridy, the onl... Read More

3) FDA Approves Newer Drug Named -Tivicay (Dolutegravir) to treat HIV infection.

The U.S. Food and Drug Administration has approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes necessary ... Read More

4) FDA Approves Roche's Avastin Plus Chemotherapy For Treatment of Advanced Cervical Cancer.

Roche (SIX: RO, ROG; OTCQX: RHHBY) recently announced that the U.S. Food and Drug Administration (FDA) approved Avastin® (Bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel Read More

5) Belinostat: First Global Approval Treatment of Peripheral T-Cell Lymphoma (PTCL).

Belinostat is first drug approval for the treatment of peripheral T–cell lymphoma (PTCL). Belinostat [Beleodaq® (US)], a small–molecule hydroxamate–type inhibitor of class I, II and IV histone deacet... Read More

6) FDA Approves New Kind of Sleeping Pill-Suvorexant (Belsomra).

The FDA recently approved Suvorexant (Belsomra) tablets to treat patients who have difficulty with falling and staying asleep. As an orexin receptor antagonist, Suvorexant alters the signaling of chemicals i... Read More